This paper presents a programmatic perspective on the relationship bet
ween the introduction of new contraceptive technology and expanding co
ntraceptive options, using the example of cyclofem in Indonesia. Past
approaches to contraceptive introduction have considered only the char
acteristics of the new method in the decision-making process. In asses
sing whether the introduction of a new method actually expands contrac
eptive choice for women and whether the program has the managerial cap
abilities to assure quality of care in this process, the authors argue
that consideration must be given to all methods within a delivery sys
tem and how new technology relates to the management of contraceptive
choice. Using this perspective, the authors suggest that choice would
not necessarily be expanded with scaled-up service delivery of a new o
nce-a month injectable in the Indonesian public sector context.